Auray JP - Search Results

1

Prevalence and clinical characteristics of migraine in France.

Henry P, Auray JP, Gaudin AF, Dartigues JF, Duru G, Lantéri-Minet M, Lucas C, Pradalier A, Chazot G, El Hasnaoui A. Henry P, et al. Among authors: auray jp. Neurology. 2002 Jul 23;59(2):232-7. doi: 10.1212/wnl.59.2.232. Neurology. 2002. PMID: 12136063

2

Use and misuse of triptans in France: data from the GRIM2000 population survey.

Lucas C, Auray JP, Gaudin AF, Dartigues JF, Duru G, Henry P, Lantéri-Minet M, Pradalier A, Chazot G, El Hasnaoui A. Lucas C, et al. Among authors: auray jp. Cephalalgia. 2004 Mar;24(3):197-205. doi: 10.1111/j.1468-2982.2003.00651.x. Cephalalgia. 2004. PMID: 15009013

3

[A new tool for evaluation of medication errors applied to pediatric hematology].

Queuille E, Bleyzac N, Auray JP, Bertrand Y, Souillet G, Philippe N, Duru G, Aulagner G. Queuille E, et al. Among authors: auray jp. Therapie. 2001 Nov-Dec;56(6):775-83. Therapie. 2001. PMID: 11878110 French.

4

[Contracts including performance and management of uncertainty].

Duru G, Garassus P, Auray JP. Duru G, et al. Among authors: auray jp. Ann Pharm Fr. 2013 Sep;71(5):338-45. doi: 10.1016/j.pharma.2013.08.008. Epub 2013 Sep 5. Ann Pharm Fr. 2013. PMID: 24075704 French.

5

[Introduction to pharmaco-economics: 'glossary'].

Auray JP. Auray JP. Therapie. 2001 Mar-Apr;56(2):89-91. Therapie. 2001. PMID: 11471379 French. No abstract available.

6

[Quality of life and economic cost of multiple sclerosis].

Grimaud J, Auray JP; Collectif SEP des villes et SEP des champs. Grimaud J, et al. Among authors: auray jp. Rev Neurol (Paris). 2004 Jan;160(1):23-34. doi: 10.1016/s0035-3787(04)70844-9. Rev Neurol (Paris). 2004. PMID: 14978391 Review. French.

7

Quality of life assessment in cosmetics: specificity and interest of the international BeautyQol instrument.

Beresniak A, Auray JP, Duru G, Aractingi S, Krueger GG, Talarico S, Tsutani K, Dupont D, de Linares Y. Beresniak A, et al. Among authors: auray jp. J Cosmet Dermatol. 2015 Sep;14(3):260-5. doi: 10.1111/jocd.12156. Epub 2015 Jul 2. J Cosmet Dermatol. 2015. PMID: 26133392

8

Impact of pigmentary disorders on quality of life in Japan: Interest of the BeautyQoL instrument.

Beresniak A, Auray JP, Duru G, Aractingi S, Krueger GG, Talarico S, Adam AS, Piot B, Dupont D, de Linares Y. Beresniak A, et al. Among authors: auray jp. J Cosmet Laser Ther. 2015;17(6):313-7. doi: 10.3109/14764172.2015.1039034. Epub 2015 Jul 2. J Cosmet Laser Ther. 2015. PMID: 25968164

9

Validation of the underlying assumptions of the quality-adjusted life-years outcome: results from the ECHOUTCOME European project.

Beresniak A, Medina-Lara A, Auray JP, De Wever A, Praet JC, Tarricone R, Torbica A, Dupont D, Lamure M, Duru G. Beresniak A, et al. Among authors: auray jp. Pharmacoeconomics. 2015 Jan;33(1):61-9. doi: 10.1007/s40273-014-0216-0. Pharmacoeconomics. 2015. PMID: 25230587

10

Difference of perceptions and evaluation of cognitive dysfunction in major depressive disorder patients across psychiatrists internationally.

El Hammi E, Samp J, Rémuzat C, Auray JP, Lamure M, Aballéa S, Kooli A, Akhras K, Toumi M. El Hammi E, et al. Among authors: auray jp. Ther Adv Psychopharmacol. 2014 Feb;4(1):22-9. doi: 10.1177/2045125313507946. Ther Adv Psychopharmacol. 2014. PMID: 24490027 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters